A STABILITY INDICATING MICELLAR LIQUID CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF DEFERASIROX IN SOLUBILIZED SYSTEM
Abstract
A simple, isocratic and stability indicating micellar liquid chromatographic (MLC) method containing a surfactant solution above its critical micellar concentration (CMC) was developed and validated for determination of Deferasirox (BTBA) content in active pharmaceutical ingredient and its pharmaceutical formulations. The analysis was performed in on isocratic mode at 400C temperature through Thermo Hypersil ODS 100mm×4.6mm, 3 µm particle size columns. The UV detection wavelength was set at 250 nm in the mobile phase containing 0.1 M Cetyl trimethyl ammonium bromide (CTAB) buffer (pH – 2.5) and 10% 1-butanol. The method was successfully validated following as per the requirements of ICH guidelines. The proposed method was successfully applied as stability indicating method for determination of BTBA under different stressed conditions. The method allows accurate and reliable determination of BTBA for drug stability assay in pharmaceutical investigations.
DOI
https://doi.org/10.22270/jddt.v7i7.1612References
United States Food and Drug Administration (FDA) approves first oral drug for chronic iron overload, press release, 2005, 1-4.
Berthod A, GarcÃa-Alvarez-Coque MC, MLC, 2000, 1-5.
Ruiz-Angel M J, GarcÃa-Alvarez-Coque M C, Berthod A, Comparison of the performance of non-ionic and anionic surfactants as mobile phase additives in the RPLC analysis of basic drugs, Separ Purif Rev, 2009, 38-45.
Sechaud R, Dutreix C, Balez S, Pommier F, Dumortier T, Morisson S, Brun E, Relative bioavailability of deferasirox tablets administered without dispersion and dispersed in various drinks, J Clin Pharmacol Ther, 2008, 46, 102.
Bruin GJM, Faller T, Wiegand H, Schweitzer A, Nick H, Schneider J, Boernsen KO, Waldmeier F, Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in rats, Drug Metab Dispos, 2008, 36, 25-23.
Published
Abstract Display: 325 
PDF Downloads: 531 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.